All Stories

  1. Trop-2 as an Actionable Biomarker in Breast Cancer
  2. Evaluating triptorelin as a treatment option for breast cancer
  3. What therapies are on the horizon for HER2 positive breast cancer?
  4. Biosimilars for breast cancer
  5. An analysis of available biomarker data for targeting cyclin-dependent kinases 4 and 6 (CDK4/6) in breast cancer
  6. Defining the immunogram of breast cancer: a focus on clinical trials
  7. A clinical perspective on escalating or de-escalating adjuvant therapy in HER2+ breast cancer
  8. Cetuximab for treating non-small cell lung cancer
  9. Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date [Corrigendum]
  10. A new approach to assess drug sensitivity in cells for novel drug discovery
  11. Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date
  12. Pharmacokinetic drug evaluation of ribociclib for the treatment of metastatic, hormone-positive breast cancer
  13. Mismatch Repair Deficiency as a Predictive Biomarker for Immunotherapy Efficacy
  14. Strategies to modulate the immune system in breast cancer: checkpoint inhibitors and beyond
  15. Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management